ILMN Illumina Inc.
As of 10:37:00 AM ET · 18 min old· Couldn’t refresh just now; showing the last price
Loading chart…
- Open
- $238.50
- Previous close
- $235.99
- Day range
- 227.74 – 238.50
- 52-week range
- 112.65 – 309.35
- Volume
- 26.7K
- Avg volume (3M)
- 2.8M
- Market cap
- $35.6B
- P/E (TTM)
- 40.62
- EPS (TTM)
- $5.81
- Beta
- 1.42
- Dividend yield
- 0.00%
- Next earnings
- —
- Ex-dividend
- —
- Sector
- Healthcare
About Illumina Inc.
Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious diseases, reproductive health, and molecular diagnostics. Illumina also provides sequencing consumables, instruments, software, and support services that help laboratories generate, interpret, and manage genomic data. The company serves customers including academic institutions, genomic research centers, hospitals, pharmaceutical and biotechnology companies, and clinical laboratories. Headquartered in San Diego, California, and founded in 1998, Illumina plays a central role in making genomic analysis more widely accessible for research and healthcare applications.
| Quarter | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Oct 29, 2026(after close) | $1.36 | $1.44 | +5.9% |
| Jul 30, 2026(after close) | $2.51 | $2.62 | +4.4% |
| Jul 9, 2026(after close) | $0.04 | −$0.02 | −150.0% |
| Apr 30, 2026(after close) | $1.05 | $1.15 | +9.5% |
| Feb 25, 2026(after close) | $0.16 | $0.43 | +168.8% |
ILMN doesn’t pay a dividend.
ILMN news and filings
Loading filings…
Filings from SEC EDGAR.